Skip to main content
Top
Published in: Reactions Weekly 1/2024

01-04-2024 | Prednisolone | Case report

Thalidomide

Transiest amaurosis

Published in: Reactions Weekly | Issue 1/2024

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Huang Z, et al. Long term efficacy and safety analysis of thalidomide monotherapy in the maintenance treatment of intestinal Behcet's disease. [Chinese] Chinese Journal of Inflammatory Bowel Diseases 7 : 313-318, Oct 2023. Available from: URL: https://rs.yiigle.com/cmaid/1478738 [Chinese; summarised from a translation] Huang Z, et al. Long term efficacy and safety analysis of thalidomide monotherapy in the maintenance treatment of intestinal Behcet's disease. [Chinese] Chinese Journal of Inflammatory Bowel Diseases 7 : 313-318, Oct 2023. Available from: URL: https://​rs.​yiigle.​com/​cmaid/​1478738 [Chinese; summarised from a translation]
Metadata
Title
Thalidomide
Transiest amaurosis
Publication date
01-04-2024
Publisher
Springer International Publishing
Keyword
Prednisolone
Published in
Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-56596-2

Other articles of this Issue 1/2024

Reactions Weekly 1/2024 Go to the issue

Case report

Pembrolizumab

Case report

Atezolizumab

Case report

Capecitabine